Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Posts Tagged ‘report’

« Older Entries

In The Spread Of Cancer, A Developmental Protein Plays A Role

By on Tuesday, June 18th, 2013 | No Comments

A protein used by embryo cells during early development, and recently found in many different types of cancer, apparently serves as a switch regulating the spread of cancer, known as metastasis, report researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center in the journal Cancer Research…

Read More...

Stopping Tumor Survival In Low-Oxygen Environments

By on Monday, June 10th, 2013 | No Comments

As tumors grow, their centers are squeezed of oxygen. And so tumors must flip specific genetic switches to survive in these hypoxic environments. A series of studies funded to do only basic science and published in the journal Cell report the serendipitous discovery of a druggable target necessary for the survival of tumors in these low-oxygen environments…

Read More...

More Cancer Specialist Nurses To Improve Hospital Care

By on Friday, June 7th, 2013 | No Comments

Patients battling cancer have a better experience of care at hospitals that employ more cancer specialist nurses. Research from the University of Southampton, shows that patients of better staffed hospitals are more likely to report being given more emotional support by nurses who work well together on wards…

Read More...

Studies confirm crizotinib’s superiority to chemotherapy for ALK-positive lung cancer

By on Tuesday, June 4th, 2013 | No Comments

Research teams led by Massachusetts General Hospital (MGH) Cancer Center (a component of the Dana-Farber Cancer Institute) investigators are publishing two important studies regarding use of the targeted cancer drug crizotinib for treatment of advanced lung cancer driven by specific genetic mutations. The first reports the final results of a global, phase 3 trial showing that crizotinib is superior to standard chemotherapy for treatment of advanced ALK-positive non-small cell lung cancer (NSCLC). The second paper describes the first report of resistance to crizotinib treatment in a patient with ROS1-positive NSCLC and reveals the mechanism underlying that resistance. Both papers are being published online in the New England Journal of Medicine to coincide with the American Society of Clinical Oncology annual meeting.

Read More...

Cancer drug shortages hit 83 percent of U. S. oncologists

By on Monday, June 3rd, 2013 | No Comments

Eighty-three percent of cancer doctors report that they’ve faced oncology drug shortages, and of those, nearly all say that their patients’ treatment has been impacted, according to a new study. The results showed that shortages – which have hit especially hard among drugs to treat pediatric, gastrointestinal and blood cancers – have left physicians surveyed unable to prescribe standard chemotherapies for a range of cancers.

Read More...

Cancer drug shortages hit 83 percent of US oncologists

By on Monday, June 3rd, 2013 | No Comments

Eighty-three percent of cancer doctors report that they’ve faced oncology drug shortages, and of those, nearly all say that their patients’ treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 2013 … (more)

Read More...

New cancer drug shows promise for treating advanced melanoma

By on Monday, June 3rd, 2013 | No Comments

Researchers from UCLA’s Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.

Read More...

Reverse Stage-3 Colon Cancer – Naturally

By on Sunday, June 2nd, 2013 | No Comments

http://www.naturalhealth365.com presents a special report on how Elena Pchjolkina refused conventional chemotherapy and cured her cancer naturally. Learn how…

Read More...

Promising Early Results For Use Of Poliovirus Vaccine In Recurrent Glioblastoma

By on Friday, May 24th, 2013 | No Comments

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report…

Read More...

Terminal Cancer Patient Disease-Free: Macrobiotic Diet the Cure

By on Thursday, May 23rd, 2013 | No Comments

News report originally broadcast by Channel 8 in Cleveland, Ohio. A woman diagnosed with stage IV cancer was given only weeks to live by the medical establis…

Read More...
« Older Entries